United Therapeutics
Trade United Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About UTHR
United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin.
UTHR Key Statistics
Stock Snapshot
As of today, United Therapeutics(UTHR) shares are valued at $468.60. The company's market cap stands at 20.48B, with a P/E ratio of 18.07.
On 2026-01-14, United Therapeutics(UTHR) stock moved within a range of $468.60 to $480.57. With shares now at $468.60, the stock is trading 0.0% above its intraday low and -2.5% below the session's peak.
Trading volume for United Therapeutics(UTHR) stock has reached 376.61K, versus its average volume of 381.24K.
Over the past 52 weeks, United Therapeutics(UTHR) stock has traded between a high of $519.99 and a low of $266.98.
Over the past 52 weeks, United Therapeutics(UTHR) stock has traded between a high of $519.99 and a low of $266.98.
UTHR News
United Therapeutics Corp. (UTHR) announced an update on their ongoing clinical study. Claim 70% Off TipRanks Premium Study Overview: United Therapeutics is ru...